Oncology Central
  • Home
  • News
  • Insights
    • Insights
      • Opinion
      • Columnists
      • Journal articles
      • Events
      • Spotlights
      • In focus
      • Follow us on social media
    • ADVERT
  • Topics
    • Disease area
      • Skin
      • Breast
      • Colorectal
      • Hematologic
      • Lung
      • View all
      • Follow us on social media
    • Subject area
      • Immuno-oncology
      • Clinical trials
      • Genetics
      • Preclinical research and trials
      • Prevention and screening
      • Therapies
      • View all
    • ADVERT
  • Multimedia
    • Multimedia
      • Videos
      • Podcasts
      • Infographics
      • Webinars
      • Follow us on social media
    • ADVERT
  • Register
  • i
  • i
  • i
  • Home
  • News
  • Insights
    • Opinion
    • Columnists
    • Journal articles
    • Spotlights
    • In Focus
    • Events
  • Topics
    • Disease area
      • Skin
      • Breast
      • Colorectal
      • Hematologic
      • Lung
      • View all
    • Subject area
      • Immuno-oncology
      • Clinical trials
      • View all
  • Multimedia
    • Videos
    • Infographics
    • Podcasts
    • Webinars
  • Registration
  • Follow us on social media
  • i
  • i

Login

Please enter your username and password below, if you are not yet a member of Oncology Central remember you can register for free.

Forgot your password?

Or register via social media

Already have an account? Login here

Or register via social media

Already have an account? Login here

Most searched
  • ask the experts
  • aacr
  • asco
  • IMpower150
  • research

clinical trial

  • 9 Jan 2019 Chemotherapy

    HTX-019 2-min injection shows promise as an alternative method of administration to prevent CINV

  • 17 Sep 2018

    NICE approves dabrafenib–trametinib for BRAF+ melanoma

  • 17 Sep 2018 Journal Articles

    Reasoning the effect of immunotherapy after chemoradiation in the PACIFIC trial

  • 22 Aug 2018 Clinical trials

    Vistusertib with paclitaxel shows promise for ovarian and lung cancer in early trial

  • 21 Aug 2018 Drug development

    Chinese regulators approve Alecensa® for NSCLC, hot on heels of FDA and EMA approvals

  • 20 Aug 2018 Journal Articles

    Estimated lifetime survival benefit of tumor treating fields and temozolomide for newly diagnosed glioblastoma patients

  • 3 Aug 2018

    FDA approves first-in-class treatment for rare adrenal tumors

  • 1 Jun 2018 Prostate

    ASCO18: Abiraterone for advanced prostate cancer may be more effective for black men than white men

  • 30 May 2018 Clinical trials

    Glioblastoma vaccine yields promising interim survival results in Phase III trial

  • 25 May 2018 Lung

    Imfinzi® significantly improves overall survival in Phase III PACIFIC trial

  • 25 May 2018 Clinical trials

    ASCO18: What talks should you look out for?

  • 24 May 2018 Immuno-oncology

    Keytruda® delivers survival success in pivotal KEYNOTE-407 lung cancer trial

View More
  • About us
  • Contact Us
  • Our journals
  • Advertising & Sponsorship
  • Ambassadors
  • Twitter
  • Facebook
  • Linkedin
  • RSS
  • Oncology Central Newsletter

    Like our content? Subscribe to our weekly newsletter for news & articles direct to your inbox.


    Stay connected
    • Twitter
    • Facebook
    • Linkedin
    • RSS
  • Find a job

    Connecting talent with opportunity, have a look at our Career Center and find your ideal next career move.

    Registration

    When you create your free account, you will be able to view all articles in full and see content personally tailored for you. Register here.

    Office Info

    Oncology Central is powered by Future Science Group.
    Unitec House, 2 Albert Place, London, N3 1QB, UK,
    +44 (0)20 8371 6090

    • About us
    • Contact Us
    • Our journals
    • Advertising & Sponsorship
    • Ambassadors
    • Find a job

      Connecting talent with opportunity, have a look at our Career Center and find your ideal next career move.

      Registration

      When you create your free account, you will be able to view all articles in full and see content personally tailored for you. Register here.

      Office Info

      Oncology Central is powered by Future Science Group.
      Unitec House, 2 Albert Place, London, N3 1QB, UK,
      +44 (0)20 8371 6090

  • Future Science Group
  • Cookies Policy
  • Privacy Policy
  • Terms & Conditions
  • ©2019 Oncology Central
© 2018 Oncology Central